Connection
Cindy O'Bryant to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Cindy O'Bryant has written about Antimetabolites, Antineoplastic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.016 |
|
|
|
-
Gore L, Holden SN, Cohen RB, Morrow M, Pierson AS, O'Bryant CL, Persky M, Gustafson D, Mikule C, Zhang S, Palmer PA, Eckhardt SG. A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors. Ann Oncol. 2006 Nov; 17(11):1709-17.
Score: 0.016